NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









LabInCube Co., Ltd.

LabInCube Co., Ltd.

Private
South KoreaHealthcare & Life Scienceshttps://labincube.com/

Last Round

Series B

Mar 18, 2026

Total Funding Raised

$13.47M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

LabInCube Co., Ltd. is a materials science company that develops drug-releasing medical devices and aesthetic products using its proprietary metal-organic framework (MOF) technology platform, CUBRIX™.

Sector

Healthcare & Life Sciences

Verticals

Advanced Materials, Biotechnology, Fashion & Beauty, Drug Discovery

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

metal-organic frameworksMOFdrug deliverycosmeceuticalcontrolled releaseskin boosteraesthetic medicinematerial scienceingredient stabilizationOEM manufacturingadvanced materialsbiotechmedspa suppliesdrug developmentnanomaterials

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

LabInCube Co., Ltd. Comparables

Compare LabInCube Co., Ltd. with similar companies based on industry and business-model similarity.

LabInCube Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
PharmaResearch
64%
Humedix Co Ltd
64%
Meta Biomed Co. Ltd
61%

LabInCube Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BMar 18, 2026
Series AApr 4, 2024

LabInCube Co., Ltd. Investors

Notable investors and investment history

LabInCube Co., Ltd. investors
InvestorRounds
BNH INVESTMENTSeries B, Series A
Korea Investment PartnersSeries A
JKP PartnersSeries B
Union Investment PartnersSeries B, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 18, 2026

    $10M round led by Meta Biomed Co. Ltd.

LabInCube Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

LabInCube Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about LabInCube Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersSouth Korea
Employee Range2
Year Founded2021
Last FundingMar 18, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.